GYRE

Gyre Therapeutics Inc · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website -
Employees(FY) -
ISIN US4037831033

Performance

+19.12%

+5.4%

-10.93%

+11.63%

-53.68%

YTD

-55.38%

Profile

Advanced Technical Analysis

Technical Analysis of GYRE 2024-12-24

The stock's indicators reflect a neutral sentiment, with the Moving Average Score at 50 indicating stability, while the Oscillators Score at 46 and Technical Score at 48 suggest a lack of strong momentum in either direction. Overall, these scores imply a cautious market outlook, with potential for either bullish or bearish movements depending on...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of GYRE

Stock Rank

Recent News & Updates

2024-11-15 06:27
Gyre Therapeutics Third Quarter 2024 Earnings: EPS: US$0.013 (vs US$0.68 loss in 3Q 2023)(Simply Wall St.)
2024-11-13 06:00
Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update(GlobeNewswire)
2024-11-12 17:00
Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update(Globenewswire)
2024-10-22 16:05
Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis(GlobeNewswire)
2024-10-22 04:05
Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis(Globenewswire)
2024-10-04 10:20
Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) market cap dropped US$51m last week; Public companies bore the brunt(Simply Wall St.)
2024-10-01 16:05
Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference(GlobeNewswire)
2024-10-01 04:05
Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference(Globenewswire)
2024-09-04 16:05
Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference(GlobeNewswire)
2024-09-04 04:05
Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference(Globenewswire)
2024-08-13 06:00
Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update(GlobeNewswire)
2024-08-12 18:00
Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update(Globenewswire)
2024-08-09 07:00
Gyre Therapeutics to Present at Sidoti Virtual Investor Conference(GlobeNewswire)
2024-08-08 19:00
Gyre Therapeutics to Present at Sidoti Virtual Investor Conference(Globenewswire)
2024-08-08 16:05
Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors(GlobeNewswire)
2024-07-02 16:05
Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia(GlobeNewswire)
2024-07-02 04:05
Gyre Therapeutics Announces China's NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia(Globenewswire)
2024-06-27 07:17
Estimating The Intrinsic Value Of Gyre Therapeutics, Inc. (NASDAQ:GYRE)(Simply Wall St.)
2024-06-18 16:05
Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology(GlobeNewswire)
2024-06-18 04:05
Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology(Globenewswire)
2024-05-30 16:05
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension(GlobeNewswire)
2024-05-30 04:05
Gyre Pharmaceuticals Receives IND Approval from China's NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension(Globenewswire)
2024-05-28 16:05
Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes(GlobeNewswire)
2024-05-28 04:05
Gyre Therapeutics Announces Expected Addition to the Russell 2000 and Russell 3000 Indexes(Globenewswire)
2024-05-11 08:25
Gyre Therapeutics Reports First Quarter 2024 Earnings(Simply Wall St.)
2024-05-09 16:10
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update(GlobeNewswire)
2024-05-09 04:10
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update(Globenewswire)
2024-04-27 09:02
Public companies are Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) biggest owners and were rewarded after market cap rose by US$137m last week(Simply Wall St.)
2024-03-28 05:32
Gyre Therapeutics Inc (GYRE) Announces Full Year 2023 Financial Outcomes and Business Progress(GuruFocus.com)
2024-03-26 06:00
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update(GlobeNewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.